Source link : https://newshealth.biz/health-news/once-weekly-oral-combo-for-hiv-maintains-high-rates-of-virologic-suppression/
(MedPage Today) — A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of virologic suppression compared with standard daily oral treatment in an open-label phase II trial. In 104 virologically… Source link : https://www.medpagetoday.com/infectiousdisease/hivaids/119149 Author : Publish date : 2025-12-22 22:42:00 Copyright for syndicated content belongs to the linked […]
The post Once-Weekly Oral Combo for HIV Maintains High Rates of Virologic Suppression first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-22 22:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8